Do endothelial progenitor cells modify our strategy to treat risk factors?

Eitemau Tebyg

• Do endothelial progenitor cells modify our strategy to treat risk factors?
  gan: Tousoulis, D, et al.
  Cyhoeddwyd: (2010)
• Potential role of endothelial progenitor cells in the pathophysiology of heart failure: clinical implications and perspectives.
  gan: Andreou, I, et al.
  Cyhoeddwyd: (2006)
• Role of inflammation and oxidative stress in endothelial progenitor cell function and mobilization: therapeutic implications for cardiovascular diseases.
  gan: Tousoulis, D, et al.
  Cyhoeddwyd: (2008)
• Circulating endothelial progenitor cells as biomarkers for prediction of cardiovascular outcomes.
  gan: Bakogiannis, C, et al.
  Cyhoeddwyd: (2012)
• The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development.
  gan: Briasoulis, A, et al.
  Cyhoeddwyd: (2011)